Loading...
VTR logo

Ventas, Inc.NYSE:VTR Rapporto sulle azioni

Cap. di mercato US$42.7b
Prezzo delle azioni
US$87.69
US$93.1
5.8% sottovalutato sconto intrinseco
1Y34.6%
7D-0.1%
Valore del portafoglio
Vista

Ventas, Inc.

Report azionario NYSE:VTR

Capitalizzazione di mercato: US$42.7b

Ventas (VTR) Panoramica del titolo

Ventas, Inc. è una società di investimento immobiliare leader nell'indice S&P 500 che permette di creare ambienti eccezionali a beneficio di una popolazione anziana in crescita. Maggiori dettagli

VTR analisi fondamentale
Punteggio fiocco di neve
Valutazione3/6
Crescita futura3/6
Prestazioni passate4/6
Salute finanziaria1/6
Dividendi3/6

VTR Community Fair Values

Create Narrative

See what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.

Concorrenti di Ventas, Inc.

Storia dei prezzi e prestazioni

Riepilogo dei massimi, dei minimi e delle variazioni dei prezzi delle azioni per Ventas
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$87.69
Massimo di 52 settimaneUS$88.76
Minimo di 52 settimaneUS$61.76
Beta0.76
Variazione di 1 mese3.21%
Variazione a 3 mesi4.52%
Variazione di 1 anno34.64%
Variazione a 3 anni85.86%
Variazione a 5 anni61.58%
Variazione dall'IPO2,889.43%

Notizie e aggiornamenti recenti

Seeking Alpha Apr 28

Ventas: Senior Housing Growth Appears Priced In

Summary Ventas (VTR) has marginally outperformed U.S. REIT peers in 2026, building on the strong returns achieved in 2025. This comes as VTR reported solid Q1 2026 results and lifted its full-year outlook, citing higher occupancy in senior housing and increased investment volumes. With occupancy for the U.S. portfolio already increasing in 2024-2026, the end of outsized normalized FFO growth, partially driven by occupancy gains, may come in the next few years. VTR's net operating income outside senior housing only grew 2% Y/Y, in line with long-term inflation and most REIT peers. The company is conservatively funding portfolio growth with share issuance, reducing risks in the near term, but potentially resulting in a drag on returns in the long term. Read the full article on Seeking Alpha
Aggiornamento dell'analisi Apr 24

VTR: Higher Dividend And Earnings Outlook Will Support Bullish Cash Flow Trajectory

Analysts have adjusted their price target on Ventas slightly higher to $93.10 from $92.95, reflecting updated views on fair value, discount rate, profit margin, and future P/E assumptions. What's in the News Company issued full year 2026 earnings guidance, projecting net income attributable to common stockholders of US$260 million to US$310 million, or US$0.52 to US$0.62 per share (Company guidance) Board of Directors declared a quarterly cash dividend of US$0.52 per share, described as an 8% increase, payable on April 16, 2026 to stockholders of record on March 31, 2026 (Company announcement) Management linked the dividend decision to expectations for cash flow growth and a positive outlook, which indicates how they are currently thinking about capital returns to shareholders (Company announcement) Valuation Changes Fair Value: Price target moved slightly to $93.10 from $92.95, a small upward adjustment.
Aggiornamento dell'analisi Apr 08

VTR: Higher Dividend And Earnings Outlook Will Support Bullish Future P/E

Analysts have adjusted their fair value estimate for Ventas slightly higher to $92.95 from $92.50. This reflects updated views on the discount rate, revenue growth, profit margin, and expected future P/E levels.

Recent updates

Seeking Alpha Apr 28

Ventas: Senior Housing Growth Appears Priced In

Summary Ventas (VTR) has marginally outperformed U.S. REIT peers in 2026, building on the strong returns achieved in 2025. This comes as VTR reported solid Q1 2026 results and lifted its full-year outlook, citing higher occupancy in senior housing and increased investment volumes. With occupancy for the U.S. portfolio already increasing in 2024-2026, the end of outsized normalized FFO growth, partially driven by occupancy gains, may come in the next few years. VTR's net operating income outside senior housing only grew 2% Y/Y, in line with long-term inflation and most REIT peers. The company is conservatively funding portfolio growth with share issuance, reducing risks in the near term, but potentially resulting in a drag on returns in the long term. Read the full article on Seeking Alpha
Aggiornamento dell'analisi Apr 24

VTR: Higher Dividend And Earnings Outlook Will Support Bullish Cash Flow Trajectory

Analysts have adjusted their price target on Ventas slightly higher to $93.10 from $92.95, reflecting updated views on fair value, discount rate, profit margin, and future P/E assumptions. What's in the News Company issued full year 2026 earnings guidance, projecting net income attributable to common stockholders of US$260 million to US$310 million, or US$0.52 to US$0.62 per share (Company guidance) Board of Directors declared a quarterly cash dividend of US$0.52 per share, described as an 8% increase, payable on April 16, 2026 to stockholders of record on March 31, 2026 (Company announcement) Management linked the dividend decision to expectations for cash flow growth and a positive outlook, which indicates how they are currently thinking about capital returns to shareholders (Company announcement) Valuation Changes Fair Value: Price target moved slightly to $93.10 from $92.95, a small upward adjustment.
Aggiornamento dell'analisi Apr 08

VTR: Higher Dividend And Earnings Outlook Will Support Bullish Future P/E

Analysts have adjusted their fair value estimate for Ventas slightly higher to $92.95 from $92.50. This reflects updated views on the discount rate, revenue growth, profit margin, and expected future P/E levels.
Aggiornamento dell'analisi Mar 25

VTR: 2026 Dividend Increase And Earnings Guidance Will Support Bullish P/E Outlook

Analysts now place Ventas' fair value at $92.50, up from $90.90. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E levels.
Aggiornamento dell'analisi Mar 10

VTR: 2026 Earnings Outlook And Dividend Increase Will Support Balanced P/E Expectations

Analysts have nudged their price target on Ventas up by about $1, reflecting slightly adjusted fair value, discount rate, and forward P/E assumptions in their models. What's in the News Ventas issued full year 2026 earnings guidance, projecting net income attributable to common stockholders in a range of $260m to $310m, or $0.52 to $0.62 per share (company guidance).
Aggiornamento dell'analisi Feb 24

VTR: 2026 Earnings Guidance And Dividend Policy Will Support P/E Upside

Analysts have increased their price target on Ventas from $87.75 to $89.50. The change reflects small adjustments to their model assumptions regarding the discount rate, revenue growth, profit margin and future P/E expectations.
Aggiornamento dell'analisi Feb 09

VTR: Steady Fair Value And 2026 Guidance Will Support P/E Upside

Analysts have lifted their price target on Ventas from $85.65 to $87.75, citing updated assumptions that combine slightly lower revenue growth with higher expected profit margins, a reduced discount rate, and a lower future P/E multiple. What's in the News Board of Directors declared a quarterly dividend of $0.52 per share, which the company describes as an 8% increase.
Aggiornamento dell'analisi Jan 26

VTR: Steady Fair Value And Higher 2025 Guidance Will Support P/E Upside

Analysts have kept their fair value estimate for Ventas steady at US$85.65, with only marginal tweaks to inputs such as the discount rate, profit margin and forward P/E assumptions that guide the updated price target rationale. What's in the News Ventas updated its full-year 2025 earnings guidance, with attributable net income per share now expected in a range of US$0.49 to US$0.52, compared with the prior range of US$0.47 to US$0.52 (Key Developments).
Aggiornamento dell'analisi Jan 12

VTR: Raised 2025 Earnings Guidance Will Support Attractive Forward P/E Upside

Analysts now set their fair value estimate for Ventas at $85.65, up slightly from $85.15. This reflects small adjustments to assumptions for the discount rate, revenue growth, profit margin, and forward P/E ratio.
Aggiornamento dell'analisi Dec 27

VTR: Full Year 2025 Guidance Will Support Steady Earnings Outlook

Analysts have modestly raised their price target on Ventas to approximately 85.15 dollars from 84.70 dollars, reflecting slightly lower discount rate assumptions and a marginally higher long term valuation multiple. What's in the News Raised full year 2025 earnings guidance, increasing expected attributable net income per share to a range of 0.49 to 0.52 dollars from the prior 0.47 to 0.52 dollars (company guidance) Valuation Changes Fair Value: risen slightly from 84.70 dollars to 85.15 dollars per share, reflecting a modest upward adjustment in intrinsic valuation.
Aggiornamento dell'analisi Dec 13

VTR: Full Year 2025 Guidance Will Support Improved Profitability Outlook

Analysts have modestly raised their price target on Ventas from 82.95 dollars to 84.70 dollars, citing slightly faster anticipated revenue growth, marginally improved profit margins, and a lower discount rate that together support a higher future earnings multiple. What's in the News Ventas raised its full year 2025 earnings guidance, now expecting attributable net income per share of 0.49 to 0.52 dollars, up from the prior range of 0.47 to 0.52 dollars (company guidance) Valuation Changes Fair Value Estimate has risen slightly to 84.70 dollars from 82.95 dollars, reflecting a modestly higher intrinsic valuation.
Aggiornamento dell'analisi Nov 29

VTR: Full Year 2025 Guidance Will Drive Improved Profitability Outlook

Analysts have raised their price target for Ventas from $79.90 to $82.95, citing stronger revenue growth and improved profit margin projections as key factors supporting the upward revision. What's in the News Ventas, Inc.
Aggiornamento dell'analisi Nov 15

VTR: Full Year 2025 Guidance Update Will Support Balanced Valuation Outlook

Analysts have revised their price target for Ventas upward from $78.25 to $79.90. They cite slight improvements in fair value estimates and lower discount rates as reasons for the adjustment.
Aggiornamento dell'analisi Nov 01

VTR: Future Expansion And Stable Income Will Balance Sector Opportunities And Risks

Analysts have raised their price target for Ventas from $77.39 to $78.25. This reflects increased optimism about the company’s revenue growth prospects and modest adjustments in profitability expectations.
Aggiornamento dell'analisi Aug 27

Increasing Aging Demand Will Reshape Senior Housing And Medical Offices

Ventas’s consensus analyst price target saw a marginal increase to $77.28, with minimal changes in both future P/E and net profit margin, indicating little shift in the company’s underlying valuation metrics. What's in the News Ventas raised its 2025 earnings guidance, now expecting attributable net income per share of $0.47–$0.52, compared to the prior range of $0.43–$0.53.
Seeking Alpha Apr 08

Why Ventas Is Poised For Strong Long-Term Returns

Summary Ventas is a well-run REIT that's experiencing high growth, particularly in its SHOP portfolio. It carries a strong balance sheet and management has resumed meaningful dividend growth. The recent dip in price has brought the yield to 3%. Combined with high single digit FFO/share growth, VTR could deliver potential market-beating total returns. Read the full article on Seeking Alpha
Seeking Alpha Nov 10

Ventas: Growth Set To Continue In The Years Ahead

Summary Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple-net lease properties. The Q3 2024 results were solid and the company increased its normalized FFO midpoint outlook. With a valuation above private market alternatives and distressed peers, Ventas is tapping debt and equity markets to grow its portfolio and increase normalized FFO. Senior housing should continue to drive net operating income growth as occupancy in the US portfolio keeps rising. Key risks to consider include a potential increase in senior housing supply in the coming years, as well as Ventas's premium enterprise-level valuation. Read the full article on Seeking Alpha
Seeking Alpha Aug 25

Ventas: Net Operating Income Growth Concentrated In Senior Housing

Summary Ventas is a healthcare REIT focused on Senior Housing, Outpatient Medical & Research, and Net Lease properties, primarily in the United States. The REIT has outperformed the Vanguard Real Estate Index Fund ETF in 2024 with a 22% total return. While Q2 2024 results were excellent and the company increased its guidance, I think the normalized FFO multiple and market-implied cap rate are quite elevated. I propose complementing your long stock position with covered calls. Key risks to consider include growth concentrated in senior housing, low gearing following the recent stock rally, and little floating rate debt, limiting benefits from Fed rate cuts. Read the full article on Seeking Alpha
Seeking Alpha Jun 10

Ventas: 4 Reasons To Be Cautious As Bulls Try And Sell Demographic Boom 2.0

Summary "Silver Tsunami" refers to the aging baby boomer generation. Ventas, Inc. has been benefitting from this in the last 12 months and expects to benefit over the next 5 as well. We give you our Debbie Downer take with 4 reasons to be cautious. Read the full article on Seeking Alpha
Seeking Alpha Mar 27

Ventas: The Silver Tsunami Vs. A Decade Of Underperformance

Summary Ventas, Inc. has underperformed its peers and the REIT index over the past 10 years. The long-awaited Silver Tsunami of 80+-year-olds may finally be arriving, increasing occupancy and rates in senior living properties. Ventas, Inc.'s portfolio, 50% weighted to senior living properties and 23% to outpatient medical offices, is designed to ride that wave of increasing demand from older patients. Read the full article on Seeking Alpha

Rendimenti per gli azionisti

VTRUS Health Care REITsUS Mercato
7D-0.1%1.0%2.6%
1Y34.6%33.8%26.2%

Ritorno vs Industria: VTR ha superato il US Health Care REITs che ha restituito 33.8 % nell'ultimo anno.

Rendimento vs Mercato: VTR ha superato il mercato US che ha restituito 26.2 % nell'ultimo anno.

Volatilità dei prezzi

Is VTR's price volatile compared to industry and market?
VTR volatility
VTR Average Weekly Movement2.7%
Health Care REITs Industry Average Movement4.0%
Market Average Movement7.2%
10% most volatile stocks in US Market16.1%
10% least volatile stocks in US Market3.2%

Prezzo delle azioni stabile: VTR non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.

Volatilità nel tempo: La volatilità settimanale ( 3% ) di VTR è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
1983542Deb Cafarowww.ventasreit.com

Ventas, Inc. è un trust di investimento immobiliare leader nell'S&P 500 che permette di creare ambienti eccezionali a beneficio di una popolazione anziana in crescita. Con circa 1.400 proprietà in Nord America e nel Regno Unito, Ventas occupa un ruolo essenziale nell'economia della longevità. La crescita dell'azienda è alimentata dalle sue oltre 850 comunità abitative per anziani, che forniscono servizi preziosi ai residenti e consentono loro di prosperare in ambienti assistiti.

Ventas, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Ventas con la sua capitalizzazione di mercato?
VTR statistiche fondamentali
Capitalizzazione di mercatoUS$42.72b
Utili (TTM)US$260.43m
Ricavi(TTM)US$6.11b
163.7x
Rapporto P/E
7.0x
Rapporto P/S

Utili e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
VTR Conto economico (TTM)
RicaviUS$6.11b
Costo del fatturatoUS$3.64b
Profitto lordoUS$2.48b
Altre speseUS$2.21b
UtiliUS$260.43m

Ultimi utili riportati

Mar 31, 2026

Prossima data di guadagno

n/a

Utile per azione (EPS)0.54
Margine lordo40.49%
Margine di profitto netto4.26%
Rapporto debito/patrimonio netto92.2%

Come si è comportato VTR nel lungo periodo?

Vedi performance storica e confronto

Dividendi

2.4%
Rendimento attuale del dividendo
53%
Rapporto di remunerazione

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/11 07:29
Prezzo dell'azione a fine giornata2026/05/11 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Ventas, Inc. è coperta da 41 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Jacob KilsteinArgus Research Company
David RodgersBaird
Amanda SweitzerBaird